Emerson Electric Co.
NYSE:EMRIndustrial - Machinery
+$2.10 today
- Market cap
- $88.87B
- Beta
- 1.25
- P/E (TTM)
- 34.7
- EPS (TTM)
- $4.36
- Dividend yield
- 1.45%
Volume 2.90M
Average 2.88M
EMR Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Emerson Electric Co.NYSE: EMR
Accounts Payables · Q3 FY2026 · quarter ended Jun 2026
Accounts payables turns positive
Q3 FY2026 accounts payables was $135M, compared with -$27M a year earlier. Trailing-twelve-month accounts payables was $317M. Over 3 fiscal years it compounded at -38.6% a year.
Context
- Accounts payables amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near $135M or moves back toward the trailing-twelve-month quarterly average of $79.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 34M USD
- Year-over-year change
- +312.5%
- 4-year CAGR
- -24.9%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 34M | +312.5% |
| FY2024 | 2024-09-30 | (16M) | +5.9% |
| FY2023 | 2023-09-30 | (17M) | -111.6% |
| FY2022 | 2022-09-30 | 147M | +37.4% |
| FY2021 | 2021-09-30 | 107M | — |
Accounts Payables vs competitors
How EMR compares with its peers on the latest reported figures
- EMR's LTM Jun 2026 accounts payables of $317M is the 4th largest of the 8 companies compared; the peer median is $180M.
- Its year-over-year change of +1964.7% is the highest of 7, against a peer median of +328.4%.
- Accounts payables amounts to 1.7% of revenue for EMR, versus a peer median of 1.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.43B | +426.6% | -6.4% | 5.7% | |
| LTM Jun 2026 | $393M | +230.3% | +46.9% | 1.8% | |
| LTM Jun 2026 | $332M | — | -0.2% | 1.1% | |
| LTM Jun 2026 | $317M | +1964.7% | -38.6% | 1.7% | |
| LTM Jun 2026 | $180M | +453.8% | — | 3.7% | |
| LTM Sep 2026 | $77.36M | +78.6% | — | 0.9% | |
| LTM Jun 2026 | $52M | +1757.1% | -32.5% | 0.6% | |
| LTM Jun 2026 | $25.1M | +217.7% | -4.8% | 0.7% | |
| Peer median (excluding EMR) | $180M | +328.4% | -4.8% | 1.1% | |
Competitors are the stored peer set for EMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 1.42B | 1.88B | 2.26B | 1.61B | 2.25B |
| Depreciation & Amortization | 762M | 842M | 1.05B | 1.69B | 1.52B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 197M | 125M | 250M | 260M | 263M |
| Change in Working Capital | 167M | (312M) | (148M) | (151M) | (9M) |
| Accounts Receivables | (18M) | (143M) | (191M) | (99M) | (171M) |
| Inventory | (11M) | (334M) | (160M) | 122M | (1M) |
| Accounts Payables | 107M | 147M | (17M) | (16M) | 34M |
| Other Working Capital | 89M | 18M | 220M | (158M) | 129M |
| Other Non-Cash Items | 1.03B | 384M | (2.78B) | (71M) | (920M) |
| Operating Cash Flow | 3.58B | 2.92B | 637M | 3.33B | 3.1B |
| Capital Expenditures | (581M) | (531M) | (363M) | (419M) | (431M) |
| Acquisitions (Net) | (1.58B) | (4.66B) | (705M) | (8.34B) | 0 |
| Purchases of Investments | 0 | (438M) | 363M | 0 | 0 |
| Sales of Investments | 0 | 438M | 176M | 79M | 0 |
| Other Investing Activities | 38M | (140M) | 12.94B | 3.32B | (162M) |
| Investing Cash Flow | (2.12B) | (5.33B) | 12.42B | (5.36B) | (593M) |
| Debt Repayment | (812M) | 3.69B | (3.24B) | (567M) | 5.24B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (500M) | (500M) | (2.21B) | (643M) | (1.24B) |
| Dividends Paid | (1.21B) | (1.22B) | (1.2B) | (1.2B) | (1.19B) |
| Other Financing Activities | 100M | 80M | (169M) | (44M) | (7.32B) |
| Financing Cash Flow | (2.42B) | 2.05B | (6.82B) | (2.46B) | (4.51B) |
| Effect of Forex Changes | 6M | (186M) | 18M | 20M | (39M) |
| Net Change in Cash | (961M) | (550M) | 6.25B | (4.46B) | (2.04B) |
| Free Cash Flow | 2.99B | 2.39B | 274M | 2.91B | 2.67B |
Emerson Electric Co.
NYSE:EMR
Intrinsic Alpha fair value
Locked
Current Price
$162.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.